Amanat takes 100% of Cambridge Health in AED 105m deal, targets 1,000 beds

Amanat Holdings PJSC acquired the remaining 10.03% of Cambridge Health Group for AED 105 million, giving it full ownership of a 715-bed post-acute care network in the UAE and Saudi Arabia.

For healthcare CEOs and CFOs, the takeaway is capacity control: Amanat now owns the full platform as it targets more than 1,000 beds and stronger payer leverage in rehabilitation, long-term care and home healthcare.

Why Amanat bought the final stake

Amanat said on 19 June 2026 that the deal completes a phased acquisition of Cambridge Health Group, after an earlier 3% stake purchase in June 2026 lifted its holding from about 87% to about 90%. Amanat disclosed the transaction through its official press release and a Dubai Financial Market filing.

The financial base is material for a specialist operator. Cambridge Health Group reported AED 404 million in FY2025 revenue, up 11% year on year, and AED 100 million in EBITDA, up 14%, according to Amanat. In Q1 2026, Amanat said revenue rose 27%, EBITDA rose 49%, and profit increased six-fold year on year.

"With a 715 bed capacity today, a clear pathway to more than 1,000 beds."
John Ireland, Chief Executive Officer, Amanat Holdings

Full ownership is expected to add an estimated AED 9 million in annualised net profit attributable to Amanat equity holders, Amanat said. The acquisition follows a record AED 175 million dividend, equal to 7 fils per share, paid after earlier monetisation activity.

The network Amanat now controls

Cambridge Health Group operates six facilities across the UAE and Saudi Arabia, supported by more than 1,200 healthcare professionals. In the UAE, its facilities in Abu Dhabi and Al Ain place clinical operations under the Department of Health - Abu Dhabi (DOH). Dubai expansion would require Dubai Health Authority (DHA) licensing, while a Northern Emirates move would fall under the Ministry of Health and Prevention (MOHAP).

• Cambridge Hospital Khobar: 150-bed long-term care and post-acute rehabilitation facility opened in November 2024.
• Cambridge Hospital Jeddah: expanded to 200 beds after refurbishment, with a further AED 100 million, 70-bed expansion in progress.
• Cambridge Hospital Dhahran: expanded to 70 beds, with another 8 beds under licensing.
• Cambridge Hospital Abu Dhabi and Cambridge Hospital Al Ain: refurbishment and upgrade work are part of Amanat's UAE programme.

The group holds accreditations from JCI, CARF, CBAHI, and CAP. For medical directors, those accreditations affect referral confidence because rehabilitation, long-term ventilation, complex nursing and home healthcare carry higher liability exposure when transfer pathways are weak.

What operators should watch

Amanat said its 2026 capital deployed and commitments now exceed AED 285 million, excluding the AED 175 million dividend. Across the Cambridge Health Group network, Amanat cited more than AED 500 million of investment to date, mainly in Saudi Arabia.

The operating issue for UAE providers is referral control. Acute hospitals, insurers and payers have a financial interest in moving stable patients into post-acute settings when clinical risk allows. A larger Cambridge Health Group platform gives Amanat more scale with payers and more capacity to take patients who would otherwise remain in acute beds.

COOs should track DOH and DHA contracting rules, discharge criteria, home healthcare licensing and payer authorisation timelines in 2026. CFOs should watch whether post-acute bundled pricing develops in Abu Dhabi or Dubai, because a 1,000-bed regional platform could reset benchmarks for rehabilitation length of stay, nursing ratios and transfer economics.

The next number to watch is capacity. If Amanat moves Cambridge Health Group beyond 715 beds toward more than 1,000, UAE competitors will need to decide whether to build rehabilitation units, partner with a specialist operator, or protect referral flows through payer contracts.